Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines
about
An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shockMicro-scale devices for transdermal drug deliveryMicroneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunityAn evaluation of the emerging vaccines against influenza in children.Universal influenza vaccines, a dream to be realized soon.Microneedle-based vaccinesMicroneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunityMicroneedle and mucosal delivery of influenza vaccines.Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.Needleless vaccine delivery using micro-shock wavesStabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skinTwo-photon polymerization of microneedles for transdermal drug delivery.Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro.Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.Effect of microneedle design on pain in human volunteers.Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition.Intradermal delivery of vaccines: potential benefits and current challenges.Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.DNA vaccination in the skin using microneedles improves protection against influenza.Micro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns.Microneedles for drug and vaccine deliveryDevelopment of vertical SU-8 microtubes integrated with dissolvable tips for transdermal drug deliveryDevelopment and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaireMicroneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations.Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccineImmune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatmentCutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook.Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.Animal models for the study of influenza pathogenesis and therapy.Does needle size matter?Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.Intanza(®): a new intradermal vaccine for seasonal influenza.Microneedle arrays as medical devices for enhanced transdermal drug delivery.Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.Microneedle patches for vaccine delivery.Microneedles: bench to bedside.Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.Microneedle patches for vaccination in developing countries.Safety evaluation of stamp type digital microneedle devices in hairless mice.
P2860
Q27486899-1EA04488-5E76-4FAC-966F-4102F17B3603Q27489779-4C7C55F6-31C2-4CDF-B455-4A2B4EFB3ADBQ30357830-9BDB4AD0-C40F-40B1-A82D-B0F45D5C58C2Q30359375-6F18E53B-C542-4601-B364-782856E8A4BCQ30361950-D3C38BD6-7AD1-4748-841E-715872804CE8Q30380910-1E3A48FF-AC34-4BD1-B930-7C66F7AEC9ADQ30399285-6E301E9B-0A22-4B29-B833-42E3C919EFF4Q30418015-F008F738-6FC4-48A2-A70F-5AE69D2DB126Q30487666-B8505E56-4D8D-41BA-A42B-436B35BFB86BQ30501618-09EB2C33-6DB2-41DA-807F-D5FE69F85FEBQ33506637-85E5D478-FA62-4A91-8E83-414A8D421121Q33537346-9023D24A-48D4-4796-8451-45550BE5A946Q33975431-AC01513B-5468-4626-AE24-4DFD6A09E1B0Q34005731-8A33C85F-38BD-4836-BFE2-7DF2FAB6A1D5Q34048990-3A5534CD-2314-4971-BB12-FD1FD358D3B5Q34288194-850540DA-FE4D-4B16-9B36-94E8850ADD47Q34439999-B1923B26-3DB5-4C5D-B6FA-F10F73FAD732Q34601669-DE031507-91FC-4DC6-BCC7-3683DBCA63ABQ35148060-FBC8AF5E-A43C-41D8-8524-8E163B1A1A11Q36085414-D0AC9C5E-2DD0-40DE-AFB9-52436B3339C3Q36105260-75389CFD-A8E4-416F-BE63-721F0D967228Q36164749-031C103C-E4BF-477C-9953-9A73F926F69EQ36762321-B4FE356D-698B-4704-9CB5-8DF43037179DQ37139129-91FF8E1B-44A9-4929-ABFD-E635089A7134Q37187433-95F91234-2418-4AE5-B4CA-B1C127ACCDBAQ37190877-4EE7C635-D86A-4EB7-BDBE-1EA2A110D2F1Q37209757-4FF73FDC-76A9-448D-B96C-0ED1939C4B37Q37316009-961CD394-2D0F-4BE7-ABAD-FA5D8ED8C6BCQ37375954-31FA6E9C-6F52-4117-BA4F-49B12D7B1A81Q37379466-9D8C7AF0-4DA1-40D5-BE87-8A2AE005413FQ37404007-1AF06304-4515-45C0-856A-B68CCEAEC83EQ37404708-CE28C1C7-50C7-4BBB-BC57-CD14243FE2C5Q37812124-423BFDF3-9C94-4DDE-9CB2-BDF689C2D5B4Q37897542-E2F704F1-CA21-4ABC-A2F5-FAEAA0209B00Q37999873-977EC358-FFD5-4EAA-BC0E-D64BF389114FQ38178693-805D8004-D4D2-4447-9950-1A678F74C74FQ38595271-C3120581-F08F-4CC9-8978-65D7C3712528Q38630763-C53439DF-EAA3-454A-B091-87183147AF40Q38646712-9497C010-1379-4D73-A2F9-85C5DB6EC8F3Q40096330-211B1283-4DC6-4853-87E8-A76B7C6871FB
P2860
Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@ast
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@en
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@nl
type
label
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@ast
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@en
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@nl
prefLabel
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@ast
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@en
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@nl
P2093
P2860
P356
P1476
Preclinical Evaluation of Micr ...... Delivery of Influenza Vaccines
@en
P2093
Andrea Waterston Hartley
Jason B Alarcon
John A Mikszta
Noel G Harvey
P2860
P304
P356
10.1128/CVI.00387-06
P577
2007-04-01T00:00:00Z